Abstract
The most common incident cancer and cause of cancer-related deaths in women is breast cancer. The Myc gene is upregulated in many cancer types including breast cancer, and it is considered as a potential anti-cancer drug target. The present study was conducted to evaluate the Myc (gene and protein) expression pattern in an experimental mammary tumour model in rats. Thirty six Sprague Dawley rats were divided into: Experimental group (26 animals), which received the chemical carcinogen N-methyl nitrosourea (MNU) and a control group (10 animals), which received vehicle only. c-Myc oncoprotein and its mRNA expression pattern were evaluated using immunohistochemistry (IHC) and semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR), respectively, in normal rat mammary tissue and mammary tumours. The rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene was used as internal control for semi-quantitative RT-PCR. Histopathological examination of mammary tissues and tumours from MNU treated animals revealed the presence of premalignant lesions, benign tumours, in situ carcinomas and invasive carcinomas. Immunohistochemical evaluation of tumour tissues showed upregulation and heterogeneous cellular localization of c-Myc oncoprotein. The expression levels of c-Myc oncoprotein were significantly elevated (75- 91%) in all the tumours. Semi-quantitative RT-PCR revealed increased expression of c-Myc mRNA in mammary tumours compared to normal mammary tissues. Further large-scale investigation study is needed to adopt this experimental rat mammary tumour model as an in vivo model to study anti-cancer strategies directed against Myc or its downstream partners at the transcriptional or post-transcriptional level.
Highlights
Cancer is the leading cause of mortality in pets, up to 41% in dogs (Bonnet et al, 2005) and second most in humans after cardiovascular diseases (Siegel et al, 2011)
The Myc gene is upregulated in many cancer types including breast cancer, and it is considered as a potential anti-cancer drug target
The rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene was used as internal control for semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR)
Summary
Cancer is the leading cause of mortality in pets (dogs and cats), up to 41% in dogs (Bonnet et al, 2005) and second most in humans after cardiovascular diseases (Siegel et al, 2011). The basic helix-loop-helix zipper transcription factor Myc coordinates the expression of a vast and functionally varied repertoire of genes that are required for the orderly proliferation of somatic and germ cells within the body. These regulated genes control the cell cycle, cell metabolism and biosynthesis, cell architecture, and cell survival, as well as the multitude of processes that proliferating cells need to engage in their surrounding micro environment, such as angiogenesis, tissue remodelling, and recruitment of cells loaded with enzymes and growth factors needed to do this. An attempt was made to evaluate the expression pattern of Myc/Myc in chemically-induced rat mammary tumours which can serve as a model for in vivo anti-cancer studies targeted against Myc/Myc
Sign-in/Register to view highlights & summary 
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
